Your browser doesn't support javascript.
loading
Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients.
Uemoto, S; Ozawa, K; Kaido, T; Mori, A; Fujimoto, Y.
Affiliation
  • Uemoto S; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
  • Ozawa K; Hepatic Disease Research Institute, Kyoto, Japan.
  • Kaido T; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
  • Mori A; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
  • Fujimoto Y; Department of Surgery, Graduate School of Medicine, Kyoto University, Japan.
Clin Exp Immunol ; 184(1): 126-36, 2016 Apr.
Article in En | MEDLINE | ID: mdl-26560892

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methylprednisolone / T-Lymphocytes, Cytotoxic / Liver Transplantation / Tacrolimus / Graft Rejection / Immunosuppressive Agents / Mycophenolic Acid Type of study: Etiology_studies / Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Immunol Year: 2016 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methylprednisolone / T-Lymphocytes, Cytotoxic / Liver Transplantation / Tacrolimus / Graft Rejection / Immunosuppressive Agents / Mycophenolic Acid Type of study: Etiology_studies / Observational_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Exp Immunol Year: 2016 Document type: Article Affiliation country: Japan Country of publication: United kingdom